Integrins in Cancer: Novel Therapeutic Approaches
The integrins are a family of transmembrane receptors important for the cell-cell and cell-matrix interactions that relate to processes of cell adhesion, migration, invasion, angiogenesis, and survival.
The integrins are a family of transmembrane receptors important for the cell-cell and cell-matrix interactions that relate to processes of cell adhesion, migration, invasion, angiogenesis, and survival. The acquisition of integrins such as αvβ3 has been correlated to the process of tumor progression in multiple tissues, suggesting that approaches effectively targeting the integrins might inhibit or reverse progression. This supplement to ONCOLOGY, based on the symposium presented to the 31st Congress of the European Society of Medical Oncology on September 29, 2006, in Istanbul, updates information upon the current understanding of the integrins.
John M. Kirkwood, MD
Disclosures:
Dr. Kirkwood has acted as a consultant for MedImmune.
MammoScreen AI Tool Improves Diagnostic Performance of Radiologists in Detecting Breast Cancer
December 16th 2020This study demonstrated that the concurrent use of this new artificial intelligence tool alongside mammography improved the diagnostic performance of radiologists in the detection of breast cancer without prolonging their workflow.
Preliminary Results Suggest AB-MR Detects Breast Cancers that 3-D Mammograms May Miss
November 29th 2020This study found that abbreviated breast magnetic resonance imaging as a supplemental screening test in women with dense breasts shows an increase in cancer detection over digital breast tomosynthesis screening.
DeepSurv Displays Possible Benefits in Prognostic Evaluation, Treatment Recommendation
July 20th 2020The deep learning survival neural network model demonstrated the potential to provide personalized treatment recommendations based on real clinical data in patients with non-small cell lung cancer.
